Welcome to BARBRI, the trusted global leader in legal education. Continue to access the same expert-led Strafford CLE and CPE webinars you know and value. Plus, explore professional skills courses and more.
About the Course
Introduction
This CLE course will examine banking issues presented by the conflict between various states' legalization of cannabis and federal law treatment of it as a controlled substance. The panel will discuss regulatory and enforcement risks associated with financing and taking deposits from cannabis-related businesses (CRBs) and best practices for mitigating those risks. The panel will also discuss recent legislative and regulatory developments relating to certain banking activities with CRBs.
Description
While medical use of cannabis is legal in 40 states and recreational use is legal in 24 states and Washington, D.C, cannabis remains illegal at the federal level under the Controlled Substances Act (CSA). Many financial institutions will not provide banking services to CRBs due to this conflict between state and federal laws. Bank counsel must be able to navigate the regulatory complexities created by this conflict in advising banks doing business with CRBs.
Banks face inconsistent regulatory approaches taken by different administrations and different federal agencies. FinCEN issued FIN-2014-G001 to clarify how financial institutions can provide services to CRBs and set forth reporting requirements, including suspicious activity reports (SARs). The Treasury Department has indicated that FIN-2014-G001 remains in place, even though the Cole Memo, which correlated to FIN-2014-F001, was rescinded in 2018. Also, FinCEN has recently shown it will continue to enforce its 2014 Marijuana Bank Secrecy Act Guidance.
Before taking deposits or transacting business with CRBs, financial institution counsel must understand the relevant Bank Secrecy Act and anti-money laundering (AML) issues and fully comply with federal Know Your Customer (KYC) requirements. Lending to a CRB is risk-inherent because cannabis remains a Schedule I drug under the CSA. Enforcement rights for lenders may be curtailed by limiting loan enforcement remedies only to state law and in state court.
The Secure and Fair Enforcement (SAFE) Banking Act, which was introduced in 2023, prohibits federal banking regulators from penalizing banks and credit unions for serving state-legal cannabis businesses. Despite a great deal of momentum in the House, this Act did not ultimately become law and has now been reintroduced in 2025 as the Secure And Fair Enforcement Regulation (SAFER) Banking Act. The SAFER Banking Act is now the primary legislation for federal cannabis banking reform in 2025, and it offers a legal framework for cannabis banking. Under the SAFER Banking Act, CRBs operating in compliance with state law would have access to checking accounts, loans, electronic banking, and other financial products.
Listen as our authoritative panel discusses these and other issues confronting banks that contemplate taking deposits or provide financing to CRBs. The panel will also discuss steps for banks and other financial institutions to avoid regulatory pitfalls and workarounds to resolve enforcement risks.
Presented By
Mr. Alovisetti is a partner at Vicente Sederberg and chair of the firm's Corporate Department. He is recognized by Chambers and Partners as one of the top cannabis lawyers in the United States. Mr. Alovisetti focuses his practice on advising investors, companies, and other law firms on the nuances of executing corporate transactions involving licensed and ancillary cannabis companies. Prior to joining VS, he worked as an associate in the New York offices of Latham & Watkins and Goodwin, where he represented public companies and private equity sponsors and their portfolio companies in a range of corporate transactions.
Jim Landau is a Partner and a member of the firm’s Litigation Group. He represents clients in litigation before Federal, New York State and Local courts and other tribunals, including arbitration and mediation before the American Arbitration Association. Jim’s practice also focuses on providing day-to-day business counseling to cannabis and other businesses with an eye toward avoiding problems before they arise. Jim has been recognized as a New York Metro Super Lawyer® in the area of Commercial Litigation every year since 2012. In addition, Jim has received a peer review rating of AV®Preeminent on Martindale-Hubbell®. Jim has become a thought leader in the New York Cannabis legal community. He frequently writes and speaks on such topics as attorney ethics, cannabis banking and licensing of cannabis businesses. Jim is currently the President-Elect of the Westchester County Bar Association. He is Chair of the Ethics Committee of the Cannabis Law Section of the New York State Bar Association and Co-Chair of the Cannabis and CBD Litigation Committee of NYSBA’s Commercial and Federal Litigation Section. He is also a Founder and Immediate Past Co-Chair of the Westchester County Bar Association’s Cannabis Law Committee and a Director and Chair of the Regulatory Committee of the Hudson Valley Cannabis Industry Association. Jim is a past president of the White Plains Bar Association. Prior to joining the firm, Jim was an attorney at Prince Lobel & Tye LLP in Purchase, NY, McCarthy Fingar LLP in White Plains, NY, and Ellenoff, Grossman & Schole LLP, Proskauer LLP and Brown Raysman & Millstein LLP in New York City. Jim received his J.D. from Boston University School of Law and his B.A. from the University of Michigan. He is admitted to practice in New York and Pennsylvania and the United States District Courts for the Southern and Eastern Districts of New York.
Mr. Robbins serves as chair of Akerman’s Cannabis Practice, counseling clients on the evolving, complex legal and business issues impacting companies with interests in the regulated substances industries. Ranked by Chambers USA as a top lawyer in Cannabis Law and recognized in 2018 by the National Law Journal as one of the country’s “Cannabis Law Trailblazers,” he has been published and quoted in national media outlets such as U.S. News & World Report, The American Lawyer, Politico, Washington Post, Bloomberg News, and Law360. He is a founding board member of the National Cannabis Bar Association and is also an active member of the National Cannabis Industry Association. Mr. Robbins brings deep experience representing public and private companies and individuals in complex regulatory and litigation matters in the regulated substances sectors. His experience encompasses investigations and administrative and enforcement proceedings brought by federal, state, and self-regulatory bodies, including the U.S. Securities and Exchange Commission (SEC), Florida Attorney General’s Office, Florida Department of Financial Services, and Florida Office of Insurance Regulation.
-
This 90-minute webinar is eligible in most states for 1.5 CLE credits.
-
Live Online
On Demand
Date + Time
- event
Wednesday, November 12, 2025
- schedule
1:00 p.m. ET./10:00 a.m. PT
I. Legalization of cannabis at the state level: current status
II. Federal regulation
A. Controlled Substances Act
B. FIN-2014-G001 and the Cole Memo
C. DOJ vs. Treasury pronouncements
III. SAFE and SAFER Banking Acts
IV. Doing business with CRBs
A. Reporting requirements under FIN-2014-G001: SARs
B. Compliance with AML and KYC requirements and the Bank Secrecy Act
V. Enforcement issues
A. State level remedies
B. Issues in bankruptcy: federal jurisdiction
The panel will review these and other key issues:
- How have banks reacted to the legalization of cannabis in various states given its treatment as a controlled substance at the federal level?
- What were the safe harbors provided under FIN-2014-G001 and the Cole Memo, and how have policy pronouncements by the Trump administration affected them?
- What concerns should CRB lenders have in regard to remedies given the illegal nature of the underlying collateral under federal law?
- Why is compliance with AML and KYC requirements especially important before taking deposits from CRBs?
- What types of protections does the SAFER Act provide for banks and financial institutions doing business with CRBs?
Unlimited access to premium CLE courses:
- Annual access
- Available live and on-demand
- Best for attorneys and legal professionals
Unlimited access to premium CPE courses.:
- Annual access
- Available live and on-demand
- Best for CPAs and tax professionals
Unlimited access to premium CLE, CPE, Professional Skills and Practice-Ready courses.:
- Annual access
- Available live and on-demand
- Best for legal, accounting, and tax professionals
Unlimited access to Professional Skills and Practice-Ready courses:
- Annual access
- Available on-demand
- Best for new attorneys
Related Courses
Bank Boards of Directors: 2026 Key Risks and Responsibilities; Governance and Oversight Measures
Thursday, April 30, 2026
1:00 PM ET/10:00 AM PT
Debt Portability Provisions in Loan Agreements: Customary Conditions, Mechanics, Benefits, Risks, Market Trends
Wednesday, April 8, 2026
1:00 PM ET/10:00 AM PT
Digital Asset Structuring in an Evolving Regulatory Environment
Tuesday, April 7, 2026
1:00 PM ET/10:00 AM PT
Recommended Resources
Making Continuing Education Work for You, Anytime, Anywhere
- Learning & Development
- Career Advancement